WEATHERBIE CAPITAL, LLC - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 71 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
WEATHERBIE CAPITAL, LLC ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q4 2016$7,847,000
-55.4%
255,602
-2.5%
0.98%
-55.4%
Q3 2016$17,586,000
+110.1%
262,286
-6.7%
2.21%
+86.0%
Q2 2016$8,371,000
+43.3%
280,985
+41.3%
1.19%
+54.1%
Q1 2016$5,840,000
-53.0%
198,859
+25.5%
0.77%
-47.2%
Q4 2015$12,424,000
+20.3%
158,475
+15.6%
1.46%
+22.0%
Q3 2015$10,327,000
-37.3%
137,041
-2.9%
1.20%
-28.5%
Q2 2015$16,476,000
-51.8%
141,123
-2.5%
1.67%
-50.4%
Q1 2015$34,170,000
+44.6%
144,721
+15.9%
3.37%
+53.9%
Q4 2014$23,626,000
-2.0%
124,826
+23.5%
2.19%
-3.0%
Q3 2014$24,109,000
+133.2%
101,055
-35.5%
2.26%
+145.3%
Q2 2014$10,339,000
-60.3%
156,649
-37.4%
0.92%
-62.7%
Q1 2014$26,066,000
+4.3%
250,296
+3.7%
2.47%
+7.0%
Q4 2013$24,994,000
+66.4%
241,419
-13.8%
2.31%
+65.3%
Q3 2013$15,021,000
-0.8%
279,926
-18.0%
1.40%
-11.8%
Q2 2013$15,149,000341,4171.58%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 1,792,114$4,713,2604.15%
Eversept Partners, LP 1,681,149$4,421,4220.37%
Camber Capital Management LP 4,235,000$11,1380.37%
Kynam Capital Management, LP 473,975$1,246,5540.20%
GLOBEFLEX CAPITAL L P 538,559$1,416,4100.17%
Affinity Asset Advisors, LLC 202,349$532,1780.15%
GSA CAPITAL PARTNERS LLP 279,629$7350.06%
RICE HALL JAMES & ASSOCIATES, LLC 363,666$956,4420.06%
Patriot Financial Group Insurance Agency, LLC 67,000$176,2100.04%
ACADIAN ASSET MANAGEMENT LLC 1,858,000$4,8840.02%
View complete list of PUMA BIOTECHNOLOGY INC shareholders